Chemical Compound

galanthamine

CAS Registry Number 357-70-0
Back to search Request a Quote
galanthamine chemical structure
Primary Record

galanthamine

In stock
859 g
Purity
99.3 %
CAS
357-70-0

Compound Identifiers & Properties

CAS
357-70-0
PubChem CID
9651
SMILES
CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O
Canonical SMILES
COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2

Names & Synonyms

  • galanthamine
  • Galantamine
  • (-)-Galanthamine
  • Lycoremine
  • Lycoremin
  • Galantamina
  • Reminyl
  • Galantamin
  • Jilkon
  • Galanthaminum
  • (-)-Galantamine
  • Galantaminum
  • Nivalin
  • 357-70-0
  • Nivaline
  • Razadyne
  • Bodamine
  • Razadyne ER
  • Galantamine hydrobromide
  • chloro-iron
  • Lotprosin xl
  • Galzemic xl
  • Consion xl
  • Gatalin xl
  • Gazylan xl
  • Luventa xl
  • Zeebral xl
  • Acumor xl
  • Elmino xl
  • Galsya xl
  • Galanthamine base
  • Galanthamine HBr
  • Galanthamine hydrobromide
  • Reminyl (TN)
  • Reminyl XL
  • (+/-)-Galantamine
  • 1qti
  • Galantaminum [INN-Latin]
  • Galanthamine, 12
  • Razadyne (TN)
  • Nivalin (TN)
  • Galantamina [INN-Spanish]
  • (+/-)-Galanthamine
  • FURAGIN
  • Galantamine [USAN:INN]
  • Razadyne ER (TN)
  • methoxy(methyl)[?]ol
  • Galantamine, (+/-)-
  • Galantamine (USAN/INN)
  • Spectrum_001271
  • 1dx6
  • Galanthamine, (+/-)-
  • Galanthamine (Standard)
  • CHEMBL659
  • RefChem:56716
  • AC1L1TIM
  • C17H21NO3
  • GALANTAMINE [MI]
  • Prestwick0_000588
  • Prestwick1_000588
  • Prestwick2_000588
  • Prestwick3_000588
  • Spectrum3_001738
  • Spectrum4_000839
  • Spectrum5_001673
  • 0D3Q044KCA
  • GALANTAMINE [INN]
  • UNII-0D3Q044KCA
  • GALANTAMINE [HSDB]
  • GALANTAMINE [USAN]
  • D0R9VR
  • Probes1_000055
  • Probes2_000395
  • GALANTAMINE [VANDF]
  • HSDB 7361
  • Galantamine [USAN:INN:BAN]
  • SCHEMBL2577
  • NSC 100058
  • BSPBio_000436
  • BSPBio_003416
  • DTXSID2045606
  • GALANTAMINE [WHO-DD]
  • KBioGR_001417
  • KBioSS_001751
  • CHEBI:42944
  • BIDD:GT0517
  • DivK1c_000590
  • NSC-100058
  • SPBio_002655
  • BRN 0093736
  • MFCD00867189
  • BPBio1_000480
  • GTPL6693
  • orb1302305
  • SCHEMBL4696585
  • SCHEMBL7166507
  • DTXCID0025606
  • SCHEMBL29379520
  • UNII-1T835Z585R
  • ASUTZQLVASHGKV-JDFRZJQESA-
  • BDBM10404
  • CTK8F9985
  • KBio1_000590
  • KBio2_001751
  • KBio2_004319
  • KBio2_006887
  • KBio3_002636
  • CID9651
  • N06DA04
  • ASUTZQLVASHGKV-JDFRZJQESA-N
  • NINDS_000590
  • GLXC-03030
  • HMS2089H03
  • HMS3885C10
  • Pharmakon1600-01501202
  • ZINC491073
  • 1T835Z585R
  • KS-000000IN
  • MSK10278
  • AN-133
  • C17-H21-N-O3
  • CG0028
  • EBC-26461
  • HY-76299R
  • NSC100058
  • NSC759861
  • s3866
  • AKOS015965330
  • ACN-035451
  • AM62710
  • CCG-212961
  • CS-1217
  • CS-O-01567
  • DB00674
  • FH15703
  • NSC-759861
  • SDCCGMLS-0066737.P001
  • BRN-0093736
  • IDI1_000590
  • SMP1_000131
  • NCGC00017256-04
  • NCGC00017256-05
  • NCGC00017256-11
  • NCGC00017256-17
  • NCGC00024731-02
  • AC-20240
  • AC-34328
  • AJ-23165
  • AN-44509
  • AS-56354
  • HY-76299
  • J11.407C
  • LS-71039
  • SBI-0051689.P002
  • Galanthamine-O-(methyl-d3)-N-(methyl-d3)
  • 1543B
  • A1745
  • A3422
  • A3423
  • FT-0776662
  • NS00003061
  • 4-27-00-02184 (Beilstein Handbook Reference)
  • 357-70-0, 1953-04-4 [hydrobromide]
  • A11538
  • C08526
  • D04292
  • EN300-708805
  • W-5162
  • AB00053614-09
  • AB00053614_10
  • 357G700
  • AC-542/20973006
  • Q412690
  • SR-05000001783
  • (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol
  • 23173-12-8
  • A1202810
  • Galanthamine ( Jilkon, Lycoremine, Nivalin and oth
  • R-113675
  • SR-05000001783-4
  • BRD-K49481516-001-01-5
  • BRD-K49481516-004-03-5
  • BRD-K49481516-004-04-3
  • BRD-K49481516-004-09-2
  • BRD-K49481516-004-18-3
  • (4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol
  • (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol
  • B1370-343377
  • (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol
  • GNT
  • (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6,8,10(17),15-tetraen-14-ol
  • (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofurol[3a,3,2,-ef][2]benzazepin-6-ol
  • 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,6S,8aR)-rel-
  • 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-
  • (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo(8.6.1.01,12.06,17)heptadeca-6(17),7,9,15-tetraen-14-ol
  • (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol
  • (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6,8,10(17),15-tetraen-14-ol
  • (3R)-6-Methoxy-12-methyl-9bbeta,9-(ethaniminomethano)-3,4,4abeta,9b-tetrahydrodibenzofuran-3alpha-ol
  • (4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzofuro[3a,3,2-ef][2]benzoazepine-6-ol
  • (4aS,8aS)-3-Methoxy-11-methyl-4aalpha,5,9,10,11,12-hexahydro-6H-benzofuro[3a,3,2-ef][2]benzazepine-6beta-ol
  • (4aS,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6beta-ol
  • (4S,6R,9S)-12-Methyl-17-methoxy-14,2-[1]propene[1]yl[3]ylidene-3-oxa-12-azatricyclo[7.5.0.04,9]tetradecane-1(14),7-diene-6-ol
  • (8aS)-3-Methoxy-5,6,9,10,11,12-hexahydro-11-methyl-4aalphaH-benzofuro[3a,3,2-ef][2]benzazepine-6beta-ol
  • 1008759-59-8
  • 1128109-00-1
  • 1672-88-4
  • 1953-04-4
  • 69353-21-5
  • 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-
  • 6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4A.ALPHA.,6.BETA.,8AR*)-
  • 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aalpha,6beta,8ar*)-
  • 6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4AS,6R,8AS)
  • 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-
  • 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-; 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl- (7CI); Galanthamine (6CI,8CI); (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol; (-)-Galantamine; (-)-Galanthamine; 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, [4aS-(4aa,6ss,8aR*)]-; BRN 0093736; Galantamin; Galantamina; Galantamine; Jilkon; Lycoremin; Lycoremine; NSC 100058
  • 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-
  • 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,(4aS,6R,8aS)-
  • InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1